Cohance Lifesciences Limited
Cohance Lifesciences disclosed its Q4 FY26 shareholding pattern, showing that the promoter holding, which is 57.49% of total shares, is fully encumbered due to financing covenants. Ms. Susan Gentile is also named as the SBO for promoter entities.
Apr 21 2026 17:04:00
Cohance Lifesciences Limited
Cohance Lifesciences responded to an NSE query regarding increased trading volume. The company confirmed no pending undisclosed information affecting price/volume and attributed the movement to prevailing market conditions.
Apr 12 2026 23:04:00
Cohance Lifesciences Limited
COHANCE LIFESCIENCES appointed Sisir K. Mishra as Company Secretary, effective April 9, 2026. Mr. Mishra brings over two decades of experience in corporate secretarial, legal, and governance functions across diversified sectors.
Mar 30 2026 22:03:00
Cohance Lifesciences Ltd - 543064 - Appointment of Company Secretary and Compliance Officer
Cohance Lifesciences appointed Mr. Sisir K. Mishra as Company Secretary, Compliance Officer, and KMP. Mr. Mishra will assume his new roles effective from April 9, 2026, bringing over two decades of corporate secretarial and governance experience.
Mar 30 2026 22:03:00
Cohance Lifesciences Limited
Cohance Lifesciences' board approved the appointment of Mr. Sisir K. Mishra as Company Secretary, Compliance Officer, and Key Managerial Personnel. The appointment is effective from April 9, 2026, and Mr. Mishra brings over two decades of corporate secretarial and governance experience.
Mar 30 2026 22:03:00
Read More